Grant: Applied Research and Development Grants - Level 2
Southern Alberta Institute of Technology
$44,505.00
Handheld Emergency Asthma Drug Device
FY 2016-17
Summary
SAIT Polytechnic is requesting NSERC Applied Research and Development grant funding for a project toadvance the development of a novel pressurized single dose delivery device for S-1226TM, a new drugdeveloped by SolAeroMed Inc. for the treatment of severe asthma. In the future the drug is also expected totreat exacerbations of chronic obstructive pulmonary disease (COPD) and cystic fibrosis. SolAeroMed Inc., asmall Alberta company, has previously engaged with Applied Research and Innovation Services at SAIT tocreate a novel delivery system for the company's clinical trials. SolAeroMed has completed preclinical studiesand a Phase I clinical trial showing that S-1226TM is effective as well as safe at all dosing levels; a Phase IIaclinical trial to demonstrate proof of concept is currently underway.There is no dispensing technology on the market today that meets the company's needs. The components of thenew drug must be specifically combined within and propelled from the device, and reach the patient's lungswithin a short period of time, to provide a more effective and longer lasting relief of acute asthma attacks.Development of the device will greatly assist the company's commercialization.
Program
Applied Research and Development Grants - Level 2
Location
Alberta, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data
As published
Application id
486763-2015
Name nom
Tofani, Rick
Department département
Applied Research and Innovation Services
Organization id
10
Institution établissement
Southern Alberta Institute of Technology
Province en
Alberta
Province fr
Alberta
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2016
Competition year année de concours
2015
Award amount
44505
Program id
CARD2
Program name en
Applied Research and Development Grants - Level 2
Program name fr
Subventions de recherche et développement appliquée - niveau 2
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
1561
Committee name en
Applied Research and Development Grants
Committee name fr
Subventions de recherche et développement appliquée
Area of application code
1102
Area of application group en
Health, education and social services
Area of application group fr
Santé publique, éducation et services sociaux
Area of application en
Biomedical engineering
Area of application fr
Génie biomédical
Research subject code
1900
Research subject group en
Biomedical engineering
Research subject group fr
Génie biomédical
Research subject en
Biomedical engineering
Research subject fr
Génie biomédical
Partie
2
Nb partie
2
Application title
Handheld Emergency Asthma Drug Device
Keyword
NSERC
Application summary
SAIT Polytechnic is requesting NSERC Applied Research and Development grant funding for a project toadvance the development of a novel pressurized single dose delivery device for S-1226TM, a new drugdeveloped by SolAeroMed Inc. for the treatment of severe asthma. In the future the drug is also expected totreat exacerbations of chronic obstructive pulmonary disease (COPD) and cystic fibrosis. SolAeroMed Inc., asmall Alberta company, has previously engaged with Applied Research and Innovation Services at SAIT tocreate a novel delivery system for the company's clinical trials. SolAeroMed has completed preclinical studiesand a Phase I clinical trial showing that S-1226TM is effective as well as safe at all dosing levels; a Phase IIaclinical trial to demonstrate proof of concept is currently underway.There is no dispensing technology on the market today that meets the company's needs. The components of thenew drug must be specifically combined within and propelled from the device, and reach the patient's lungswithin a short period of time, to provide a more effective and longer lasting relief of acute asthma attacks.Development of the device will greatly assist the company's commercialization.
